NS
NSRGY.US Nestle SA ADR
- Market cap
- USD 269B
- P/E
- 28.7x
- P/B
- 7.65x
- ROE
- 48.7%
- Dividend yield
- 3.77%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is NSRGY.US undervalued?
Graham numberThe Graham number of Nestle SA ADR cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nestle SA ADR fundamental analysis
No fundamental analysis for Nestle SA ADR yet.
Nestle SA ADR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nestle SA ADR
Nestlé S.A., together with its subsidiaries, manufactures and distributes food and beverage, and nutritional science products in the United States, Brazil, Mexico, Greater China, the Philippines, India, the United Kingdom, France, Germany, Switzerland, and internationally. The company offers cereals, chocolate and confectionery, coffee, culinary, chilled and frozen food, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, plant-based portfolio, and …
Full company profileNestle SA ADR financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nestle SA ADR annual financial statements (CHF; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 89.8B | 89.9B | 91.8B | 92.6B | 84.3B | 87.1B | 94.4B | 93.4B | 91.7B | 85.5B | 176B |
| Gross Profit | 45.6B | 44.4B | 45.7B | 45.9B | 41.5B | 41.6B | 42.7B | 43.0B | 43.1B | 39.0B | 81.7B |
| Operating Income | 14.1B | 14.7B | 15.3B | 16.3B | 14.8B | 11.7B | 12.3B | 14.1B | 14.7B | 13.6B | 28.6B |
| EBITDA | 17.3B | 18.6B | 19.3B | 20.0B | 18.4B | 15.2B | 16.1B | 17.8B | 18.7B | 17.3B | 35.8B |
| Net Income | 8.53B | 7.16B | 10.1B | 12.6B | 12.2B | 16.9B | 9.27B | 11.2B | 10.9B | 8.63B | 14.2B |
| EPS | 2.75 | 2.31 | 3.36 | 4.30 | 4.29 | 6.06 | 3.42 | 4.23 | 4.19 | 3.35 | 5.51 |
| Balance Sheet | |||||||||||
| Total Assets | 132B | 133B | 137B | 128B | 124B | 139B | 135B | 127B | 139B | 127B | 128B |
| Total Liabilities | 65.9B | 71.0B | 78.6B | 75.1B | 77.5B | 85.4B | 92.4B | 90.2B | 103B | 94.2B | 98.5B |
| Shareholders' Equity | 64.6B | 61.0B | 57.4B | 52.0B | 45.7B | 53.1B | 42.0B | 35.7B | 35.9B | 32.8B | 29.1B |
| Cash & Short-term Investments | 9.39B | 8.75B | 10.4B | 10.3B | 8.61B | 14.0B | 6.69B | 5.85B | 7.87B | 6.24B | 6.11B |
| Total Debt | 23.2B | 29.8B | 40.4B | 37.2B | 39.9B | 46.9B | 54.3B | 55.2B | 63.6B | 57.9B | 62.6B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 15.6B | 14.2B | 15.4B | 15.9B | 14.4B | 13.9B | 11.9B | 15.9B | 16.7B | 15.2B | 21.8B |
| Capital Expenditure | 4.01B | 3.94B | 3.87B | 4.21B | 4.36B | 5.34B | 5.36B | 6.20B | 5.96B | 4.32B | 7.23B |
| Free Cash Flow | 11.6B | 10.3B | 11.5B | 11.6B | 10.0B | 8.52B | 6.55B | 9.74B | 10.7B | 10.9B | 14.6B |
| Ratios | |||||||||||
| ROE | 13.2% | 11.7% | 17.7% | 24.2% | 26.8% | 31.8% | 22.1% | 31.4% | 30.3% | 26.3% | 48.7% |
| ROA | 6.5% | 5.4% | 7.4% | 9.9% | 9.9% | 12.1% | 6.9% | 8.9% | 7.8% | 6.8% | 11.1% |
| Net Profit Margin | 9.5% | 8.0% | 11.0% | 13.6% | 14.5% | 19.4% | 9.8% | 12.0% | 11.9% | 10.1% | 8.1% |
| Debt to Equity | 0.36x | 0.49x | 0.70x | 0.71x | 0.87x | 0.88x | 1.29x | 1.55x | 1.77x | 1.76x | 2.15x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nestle SA ADR dividends
- Dividend yield
- 3.77%
- Forward dividend
- 3.94 USD
- Payout ratio
- 86.9%
- Ex-dividend date
- Apr 21, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CHF 7.50B | 2.91 | 86.9% |
| 2024 | CHF 7.82B | 3.01 | 71.8% |
| 2023 | CHF 7.83B | 2.96 | 69.8% |
| 2022 | CHF 7.62B | 2.81 | 82.2% |
| 2021 | CHF 7.68B | 2.75 | 45.4% |
| 2020 | CHF 7.70B | 2.70 | 62.9% |
| 2019 | CHF 7.23B | 2.46 | 57.3% |
| 2018 | CHF 7.12B | 2.36 | 70.3% |
| 2017 | CHF 7.13B | 2.30 | 99.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 25:10 on Jul 3, 2008.
Who owns Nestle SA ADR
- Insiders 0.00%
- Institutions 0.72%
- Public & others 99.29%
- Shares outstanding 2.57B
- Free float 2.57B
Nestle SA ADR company profile
- Company name
- Nestle SA ADR
- Ticker
- NSRGY.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 271,000
- Fiscal year end
- December
- Address
- Avenue Nestlé 55, Vevey, Switzerland, 1800
- Phone
- 41 21 924 1111
- Website
- nestle.com
About Nestle SA ADR
Nestlé S.A., together with its subsidiaries, manufactures and distributes food and beverage, and nutritional science products in the United States, Brazil, Mexico, Greater China, the Philippines, India, the United Kingdom, France, Germany, Switzerland, and internationally. The company offers cereals, chocolate and confectionery, coffee, culinary, chilled and frozen food, dairy, drinks, food service, ice cream, nutrition and health, petcare, water, plant-based portfolio, and recipe products. It sells its products under the Nesquik Cereal, Fitness, Cheerios, Lion Cereals, Cini Minis, KitKat Cereal, Chocapic, Koko Krunch, Shreddies, Shredded Wheat Original, Corn Flakes, Trix Cereal, Aero, Baci Perugina, KitKat, Milkybar, Smarties, Cailler, Quality Street, Garoto, Nestlé Toll House, Munch, Damak, Hsu Fu Chi, Sahne Nuss, Nestlé Sustainably Sourced Cocoa, Blue Bottle Coffee, Nescafé, Nescafé Dolce Gusto, Nespresso, Starbucks Coffee At Home, DiGiorno, Garden Gourmet, Maggi, Thomy, Stouffer's, Hot Pockets, Lean Cuisine, Life Cuisine, Buitoni, Nestlé carnation, Nestlé Coffee Mate, and Nestea brands. The company also offers its products under the Roastelier by Nescafé, Plant-based and so good!, Milo, Chef, Maggi Professional, La Lechera, Minor's, Antica Gelateria Del Corso, Drumstick, Extrême, Häagen-Dazs, Maxibon, Mövenpick, Nancare, Gerber, Cerelac, Nestum, Alfaré HMO, Athéra HMO, Alfamino HMO, Bear Brand, Nido, Orgain, Nestlé Vital, Garden of Life, Pure Encapsulations, Solgar, Compleat, Impact, Peptamen, Vitaflo, Resource, Cat Chow, Dentalife, Dog Chow, Fancy Feast, Felix, Friskies, Gourmet, Purina, Purina ONE, Purina Pro Plan, Purina Pro Plan Veterinary Diets, Acqua Panna, Nestlé Pure Life, Perrier, S.Pellegrino, Sanpellegrino, Buxton, Erikli, Levissima, Vittel, Contrex, HENNIEZ, Hépar, La Vie, Naleczowianka, and Essentia brands. The company was founded in 1866 and is headquartered in Vevey, Switzerland. Aimmune Therapeutics, Inc. operates as a subsidiary of Nestlé S.A.
Nestle SA ADR management
10- Mr. Philipp NavratilCEO & Member of the Executive Board · born 1976
- Ms. Anna Olive Magdelene ManzExecutive VP, CFO & Member of Executive Board · born 1973
- Mr. Stefan PalzerExecutive VP, CTO & Member of Executive Board · born 1969
- Ms. Leanne D. GealeExecutive VP, Group General Counsel & Member of the Executive Board · born 1965
- Mr. David RennieExecutive VP, Head of Strategic Business Units, Marketing & Sales and Member of Executive Board · born 1966
- Mr. Remy EjelExecutive VP, CEO of Zone Asia, Oceania & Africa and Member of Executive Board · born 1969
- Ms. Stephanie Pullings HartExecutive VP, COO & Member of Executive Board · born 1972
- Mr. Guillaume Le CunffExecutive VP, CEO of Zone Europe & Member of Executive Board · born 1970
- Ms. Anna LenzExecutive VP, Global Head of Human Resources & Member of Executive Board · born 1980
- Mr. Jeff HamiltonExecutive VP, CEO of Zone Americas (AMS) & Member of Executive Board